113 related articles for article (PubMed ID: 3500161)
1. beta-Lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistance.
Livermore DM; Chau PY; Wong AI; Leung YK
J Antimicrob Chemother; 1987 Sep; 20(3):313-21. PubMed ID: 3500161
[TBL] [Abstract][Full Text] [Related]
2. Properties of cephalosporinase from Proteus morganii.
Toda M; Inoue M; Mitsuhashi S
J Antibiot (Tokyo); 1981 Nov; 34(11):1469-75. PubMed ID: 6976340
[TBL] [Abstract][Full Text] [Related]
3. Inducible beta-lactamases in clinical isolates of non-aeruginosa Pseudomonas.
Ravaoarinoro M; Toma E; Fallara A
APMIS; 1992 Jun; 100(6):523-30. PubMed ID: 1610551
[TBL] [Abstract][Full Text] [Related]
4. [Properties of a cephalosporinase produced by Proteus penneri inhibited by clavulanic acid].
Miro E; Barthelemy M; Peduzzi J; Reynaud A; Morand A; Prats G; Labia R
Pathol Biol (Paris); 1994 May; 42(5):487-90. PubMed ID: 7824319
[TBL] [Abstract][Full Text] [Related]
5. Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from Aeromonas sobria AER 14M in Escherichia coli: requirement for an E. coli chromosomal mutation for efficient expression of the class D enzyme.
Rasmussen BA; Keeney D; Yang Y; Bush K
Antimicrob Agents Chemother; 1994 Sep; 38(9):2078-85. PubMed ID: 7811022
[TBL] [Abstract][Full Text] [Related]
6. [Identification of a cephalosporinase susceptible to clavulanic acid in a clinical strain of Serratia fonticola].
Farzaneh S; Péduzzi J; Demachy MC; Barthélémy M; Labia R
Pathol Biol (Paris); 1995 Apr; 43(4):315-9. PubMed ID: 7567122
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
Payne DJ; Marriott MS; Amyes SG
J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
[TBL] [Abstract][Full Text] [Related]
8. Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
Neu HC
Diagn Microbiol Infect Dis; 1983 Dec; 1(4):313-6. PubMed ID: 6321094
[TBL] [Abstract][Full Text] [Related]
9. Purification and properties of a new beta-lactamase from Pseudomonas cepacia.
Hirai K; Iyobe S; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1980 Mar; 17(3):355-8. PubMed ID: 6968539
[TBL] [Abstract][Full Text] [Related]
10. Cefoxitin resistance by a chromosomal cephalosporinase in Escherichia coli.
Takahashi I; Sawai T; Ando T; Yamagishi S
J Antibiot (Tokyo); 1980 Sep; 33(9):1037-42. PubMed ID: 7002896
[TBL] [Abstract][Full Text] [Related]
11. Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
Sawai T; Tsukamoto K
J Antibiot (Tokyo); 1982 Nov; 35(11):1594-602. PubMed ID: 6298169
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
Corkill JE; Hart CA; McLennan AG; Aspinall S
J Gen Microbiol; 1991 Jun; 137(6):1425-9. PubMed ID: 1655952
[TBL] [Abstract][Full Text] [Related]
13. Purification and biochemical properties of beta-lactamase produced by Proteus rettgeri.
Matsuura M; Nakazawa H; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1980 Nov; 18(5):687-90. PubMed ID: 6969578
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cephalosporinases from Bacteroides fragilis, Bacteroides thetaiotaomicron and Bacteroides vulgatus.
Sato K; Matsuura Y; Miyata K; Inoue M; Mitsuhashi S
J Antibiot (Tokyo); 1983 Jan; 36(1):76-85. PubMed ID: 6332105
[TBL] [Abstract][Full Text] [Related]
15. Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.
Kazmierczak A; Cordin X; Duez JM; Siebor E; Pechinot A; Sirot J
J Int Med Res; 1990; 18 Suppl 4():67D-77D. PubMed ID: 2282971
[TBL] [Abstract][Full Text] [Related]
16. Five novel plasmid-determined beta-lactamases.
Medeiros AA; Cohenford M; Jacoby GA
Antimicrob Agents Chemother; 1985 May; 27(5):715-9. PubMed ID: 3925874
[TBL] [Abstract][Full Text] [Related]
17. Purification and properties of a beta-lactamase from Proteus penneri.
Grace ME; Gregory FJ; Hung PP; Fu KP
J Antibiot (Tokyo); 1986 Jul; 39(7):938-42. PubMed ID: 3489701
[TBL] [Abstract][Full Text] [Related]
18. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem.
Eley A; Greenwood D
J Med Microbiol; 1986 Feb; 21(1):49-57. PubMed ID: 3485198
[TBL] [Abstract][Full Text] [Related]
19. Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins.
Hiraoka M; Inoue M; Mitsuhashi S
Rev Infect Dis; 1988; 10(4):746-51. PubMed ID: 3055173
[TBL] [Abstract][Full Text] [Related]
20. Multiple antibiotic resistance (MAR) index and its reversion in Pseudomonas aeruginosa.
Paul S; Bezbaruah RL; Roy MK; Ghosh AC
Lett Appl Microbiol; 1997 Mar; 24(3):169-71. PubMed ID: 9080693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
